EDITORIAL
Published on 03 Apr 2023
Editorial: Systemic immune dysregulation in malignant disease: Insights, monitoring and therapeutic exploitation
doi 10.3389/fonc.2023.1182081
- 855 views
- 1 citation
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Research Topics
- Systemic immune dysregulation in malignant disease: insights, monitoring and therapeutic exploitation
Systemic immune dysregulation in malignant disease: insights, monitoring and therapeutic exploitation
23k
Total downloads
74k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 08 Feb 2023
Characterization of the immune cell landscape in CRC: Clinical implications of tumour-infiltrating leukocytes in early- and late-stage CRC
doi 10.3389/fimmu.2022.978862
- 3,042 views
- 10 citations
ORIGINAL RESEARCH
Published on 07 Nov 2022
Human papillomavirus infection can alter the level of tumour stemness and T cell infiltration in patients with head and neck squamous cell carcinoma
doi 10.3389/fimmu.2022.1013542
- 1,711 views
- 4 citations
ORIGINAL RESEARCH
Published on 31 Oct 2022
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors
doi 10.3389/fonc.2022.1010660
- 2,247 views
- 11 citations
ORIGINAL RESEARCH
Published on 11 Oct 2022
The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer
doi 10.3389/fonc.2022.891511
- 2,168 views
- 12 citations
ORIGINAL RESEARCH
Published on 11 Aug 2022
Phenotypic and functional analysis of γδ T cells in the pathogenesis of human T-cell lymphotropic virus type 1 infection
doi 10.3389/fimmu.2022.920888
- 4,166 views
- 1 citation
ORIGINAL RESEARCH
Published on 22 Jul 2022
A New Thinking: Deciphering the Aberrance and Clinical Implication of IGF Axis Regulation Pattern in Clear Cell Renal Cell Carcinoma
doi 10.3389/fimmu.2022.935595
- 1,757 views
- 7 citations
ORIGINAL RESEARCH
Published on 30 Jun 2022
Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods
doi 10.3389/fimmu.2022.862752
- 4,165 views
- 13 citations
REVIEW
Published on 02 Jun 2022
Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer
doi 10.3389/fimmu.2022.903562
- 15,889 views
- 19 citations
ORIGINAL RESEARCH
Published on 25 Jan 2022
Picturing of the Lung Tumor Cellular Composition by Multispectral Flow Cytometry
doi 10.3389/fimmu.2022.827719
- 6,611 views
- 6 citations
ORIGINAL RESEARCH
Published on 18 Jan 2022
Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer
doi 10.3389/fimmu.2021.754138
- 2,904 views
- 9 citations
ORIGINAL RESEARCH
Published on 03 Jan 2022
Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization
doi 10.3389/fimmu.2021.798811
- 5,185 views
- 13 citations
Published in
Frontiers in Oncology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore